Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenoma D000236 40 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Fabry Disease D000795 4 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Edema D004487 152 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Eye Abnormalities D005124 7 associated lipids
Fibrosis D005355 23 associated lipids
Glioblastoma D005909 27 associated lipids
Glioma D005910 112 associated lipids
Heart Failure D006333 36 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Influenza, Human D007251 11 associated lipids
Insulin Resistance D007333 99 associated lipids
Insulinoma D007340 28 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Lung Neoplasms D008175 171 associated lipids
Melanoma D008545 69 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Cardiomyopathies D009202 10 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neuralgia D009437 28 associated lipids
Neuroblastoma D009447 66 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Ovarian Diseases D010049 5 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Proteinuria D011507 30 associated lipids
Psoriasis D011565 47 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Retinal Detachment D012163 10 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Sarcoma 180 D012510 21 associated lipids
Sensation Disorders D012678 2 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Tuberculosis D014376 20 associated lipids
Vascular Diseases D014652 16 associated lipids
Reperfusion Injury D015427 65 associated lipids
Weight Gain D015430 101 associated lipids
Teratocarcinoma D018243 7 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Endotoxemia D019446 27 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Ileus D045823 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Lung Injury D055370 14 associated lipids
Acute Lung Injury D055371 33 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Jin YX et al. Sphingosine kinase assay system with fluorescent detection in high performance liquid chromatography. 2006 Arch. Pharm. Res. pmid:17146975
Giussani P et al. Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells. 2007 Neurochem. Res. pmid:17151916
Fisher KE et al. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. 2006 Mol. Cancer pmid:17156449
Pchejetski D et al. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. 2007 Circ. Res. pmid:17158340
Keul P et al. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17158351
Walter DH et al. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17158356
Jang S et al. Cytochemical alterations in the rat retina by LPS administration. 2007 Neurochem. Res. pmid:17160463
Taha TA et al. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. 2006 Biochim. Biophys. Acta pmid:17161984
Jeng YJ et al. Progesterone-induced sphingosine kinase-1 expression in the rat uterus during pregnancy and signaling consequences. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17164439
Harvey KA et al. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation. 2007 J. Cell. Physiol. pmid:17167780
Huwiler A and Pfeilschifter J Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. 2006 Curr. Pharm. Des. pmid:17168766
Deng Q et al. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies. 2007 Mol. Pharmacol. pmid:17170199
Koh E et al. Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors. 2007 Cancer Lett. pmid:17189669
Soares R and Azevedo I Inhibition of S1P by polyphenols prevents inflammation and angiogenesis: NFkappaB, a downstream effector? 2007 Free Radic. Biol. Med. pmid:17189836
Barthomeuf C Inhibition of S1P-induced angiogenesis, metastasis and inflammation by dietary polyphenols. 2007 Free Radic. Biol. Med. pmid:17189837
Maceyka M et al. Shooting the messenger: oxidative stress regulates sphingosine-1-phosphate. 2007 Circ. Res. pmid:17204658
Guo Y et al. Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. 2007 Mol. Cell Proteomics pmid:17210631
Martino A et al. Sphingosine 1-phosphate interferes on the differentiation of human monocytes into competent dendritic cells. 2007 Scand. J. Immunol. pmid:17212771
Hänel P et al. Erythrocytes store and release sphingosine 1-phosphate in blood. 2007 FASEB J. pmid:17215483
Gonzalez-Cabrera PJ et al. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics. 2007 J. Biol. Chem. pmid:17218309
Igarashi J et al. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. 2007 Br. J. Pharmacol. pmid:17220911
Currie JC et al. MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival. 2007 J. Biol. Chem. pmid:17229722
Beech DJ Bipolar phospholipid sensing by TRPC5 calcium channel. 2007 Biochem. Soc. Trans. pmid:17233612
Kunisawa J et al. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production. 2007 Blood pmid:17234743
Nofer JR et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. 2007 Circulation pmid:17242282
Alemany R et al. Regulation and functional roles of sphingosine kinases. 2007 Naunyn Schmiedebergs Arch. Pharmacol. pmid:17242884
Inniss K and Moore H Mediation of apoptosis and proliferation of human embryonic stem cells by sphingosine-1-phosphate. 2006 Stem Cells Dev. pmid:17253942
Novgorodov AS et al. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. 2007 FASEB J. pmid:17255471
Matsuyuki H et al. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. 2006 Cell. Mol. Immunol. pmid:17257496
Baranowski M et al. Pioglitazone induces de novo ceramide synthesis in the rat heart. 2007 Prostaglandins Other Lipid Mediat. pmid:17259076
Herr DR and Chun J Effects of LPA and S1P on the nervous system and implications for their involvement in disease. 2007 Curr Drug Targets pmid:17266539
Rosen H et al. Tipping the gatekeeper: S1P regulation of endothelial barrier function. 2007 Trends Immunol. pmid:17276731
Peters SL and Alewijnse AE Sphingosine-1-phosphate signaling in the cardiovascular system. 2007 Curr Opin Pharmacol pmid:17280869
Tellier E et al. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. 2007 Mol. Cell. Biol. pmid:17283058
Jiang LI et al. Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. 2007 J. Biol. Chem. pmid:17283075
Kono M et al. Deafness and stria vascularis defects in S1P2 receptor-null mice. 2007 J. Biol. Chem. pmid:17284444
Herr DR et al. Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. 2007 J. Neurosci. pmid:17287522
Means CK et al. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17293497
Formigli L et al. Cytoskeleton/stretch-activated ion channel interaction regulates myogenic differentiation of skeletal myoblasts. 2007 J. Cell. Physiol. pmid:17295211
Baumruker T et al. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis. 2007 Expert Opin Investig Drugs pmid:17302523
Baran Y et al. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. 2007 J. Biol. Chem. pmid:17303574
Chandru H and Boggaram V The role of sphingosine 1-phosphate in the TNF-alpha induction of IL-8 gene expression in lung epithelial cells. 2007 Gene pmid:17306937
Koh E et al. Sphingosine-1-phosphate initiates rapid retraction of pseudopodia by localized RhoA activation. 2007 Cell. Signal. pmid:17307336
Jung ID et al. Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells. 2007 Int. Immunol. pmid:17307797
Bonnaud S et al. Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. 2007 Cancer Res. pmid:17308123
Pilorget A et al. Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells. 2007 J. Neurochem. pmid:17316399
Tao R et al. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. 2007 Cardiovasc. Res. pmid:17320845
Roviezzo F et al. Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17322125
Kajimoto T et al. Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. 2007 Mol. Cell. Biol. pmid:17325039
Nombela-Arrieta C et al. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. 2007 J. Exp. Med. pmid:17325199